Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

8.170 +0.350 (+4.48%)

Official Closing Price Updated: 7:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2021 ↗

October 13, 2021

Upgrades DA Davidson upgraded the previous rating for Columbia Banking System Inc (NASDAQ:

Via Benzinga

Never Mind Ginkgo Bioworks' Drama -- This Synthetic Biology Stock Is Still a Buy ↗

October 13, 2021

If the latest short-seller attack on Ginkgo Bioworks has you nervous about synthetic biology, consider the industry leader.

Via The Motley Fool

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

October 12, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

DNA Stock: The Bull Call That Has Ginkgo Bioworks Bouncing Back After Last Week’s “Scam” Accusation ↗

October 12, 2021

Ginkgo Bioworks (DNA) stock is doing well on Tuesday as it recovers with new coverage from an analyst with a bull stance.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021 ↗

October 12, 2021

Upgrades For Callaway Golf Co (NYSE:ELY), Compass ...

Via Benzinga

46 Biggest Movers From Yesterday ↗

October 12, 2021

Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’...

Via Benzinga

GINKGO BIOWORKS INVESTOR ALERT

October 11, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

October 11, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

28 Stocks Moving In Monday's Mid-Day Session ↗

October 11, 2021

Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical...

Via Benzinga

Cathie Wood's Ark Invest Piles Up Another $15.8M In Gingko On Dip Amid Short-Seller Allegations ↗

October 11, 2021

Cathie Wood-led Ark Invest on Friday snapped up more shares in Ginkgo Bioworks Holdings Inc (NYSE: DNA) on the dip. The popular money manager’s investment firm snapped up 1....

Via Benzinga

GINKGO BIOWORKS SHAREHOLDER NOTICE

October 10, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

GINKGO BIOWORKS SHAREHOLDER ALERT

October 08, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

October 09, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

GINKGO ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Ginkgo Stockholders and Encourages Investors to Contact the Firm

October 07, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

October 07, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

GINKGO BIOWORKS INVESTOR ALERT

October 07, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

DNA Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) Investors

October 07, 2021

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

October 07, 2021

From The Schall Law Firm

Via Business Wire

40 Biggest Movers From Yesterday ↗

October 07, 2021

Gainers Volcon, Inc. (NASDAQ: VLCN) shares jumped 97.5% to settle at $10.86 on Wednesday as the company priced its IPO at $5.50 per share. Voyager Therapeutics, Inc. (NASDAQ:...

Via Benzinga

Topics Initial Public Offering

Cathie Wood Sells $49.4M In Tesla And Buys $87.5M In Ginkgo Bioworks On Dip As Stock Becomes Target Of Short Sellers ↗

October 06, 2021

Cathie Wood-led Ark Invest on Wednesday snapped up shares in Ginkgo Bioworks Holdings Inc (NYSE: DNA) on the day the synthetic biology company stock was hit hard by two back-to-...

Via Benzinga

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors

October 06, 2021

From Glancy Prongay & Murray LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors

October 06, 2021

From Cruz The Law Offices of Frank R. Cruz

Via Business Wire

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

October 06, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors

October 06, 2021

From Law Offices of Howard G. Smith

Via Business Wire

GINKGO BIOWORKS INVESTOR ALERT - Investors Who Have Suffered Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C.

October 06, 2021

PHILADELPHIA, PA / ACCESSWIRE / October 6, 2021 / Kehoe Law Firm, P.C. is investigating whether Ginkgo Bioworks ("Ginkgo" or the "Company") (NYSE:DNA) violated federal securities laws. Ginkgo investors...

From Kehoe Law Firm, P.C.

Via AccessWire

Topics Fraud

DNA Stock: 7 Things to Know About the Short Report Hammering Ginkgo Bioworks ↗

October 06, 2021

Today, Ginko Bioworks and DNA stock are firmly in the sights of short-sellers as various claims are made about an elaborate fraud underway.

Via InvestorPlace

Topics Fraud

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

October 06, 2021

From The Schall Law Firm

Via Business Wire

Ginkgo Bioworks Stock Drops 20% After Short Sellers Call Company A 'Colossal Scam' ↗

October 06, 2021

Shares of synthetic biology company Ginkgo Bioworks Holdings Inc (NYSE:

Via Benzinga

26 Stocks Moving In Wednesday's Mid-Day Session ↗

October 06, 2021

Gainers Voyager Therapeutics, Inc. (NASDAQ: VYGR) shares jumped 54.1% to $3.8050 after the company announced licensing option agreement with Pfizer for capsids generated from...

Via Benzinga

Here's Why This Cathie Wood Stock Is Crashing Today ↗

October 06, 2021

Scorpion Capital is shooting some venom at a new target today.

Via The Motley Fool

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Starting at $3.75/week.

Subscribe Today